State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach.

Journal Article (Journal Article)

PURPOSE: National Cancer Institute (NCI)-sponsored clinical trial network studies frequently require biopsy specimens for pharmacodynamic and molecular biomarker analyses, including paired pre- and post-treatment samples. The purpose of this meeting of NCI-sponsored investigators was to identify local institutional standard procedures found to ensure quantitative and qualitative specimen adequacy. METHODS: NCI convened a conference on best biopsy practices, focusing on the clinical research community. Topics discussed were (1) criteria for specimen adequacy in the personalized medicine era, (2) team-based approaches to ensure specimen adequacy and quality control, and (3) risk considerations relevant to academic and community practitioners and their patients. RESULTS AND RECOMMENDATIONS: Key recommendations from the convened consensus panel included (1) establishment of infrastructure for multidisciplinary biopsy teams with a formalized information capture process, (2) maintenance of standard operating procedures with regular team review, (3) optimization of tissue collection and yield methodology, (4) incorporation of needle aspiration and other newer techniques, and (5) commitment of stakeholders to use of guideline documents to increase awareness of best biopsy practices, with the goal of universally improving tumor biopsy practices.

Full Text

Duke Authors

Cited Authors

  • Levy, EB; Fiel, MI; Hamilton, SR; Kleiner, DE; McCall, SJ; Schirmacher, P; Travis, W; Kuo, MD; Suh, RD; Tam, AL; Islam, SU; Ferry-Galow, K; Enos, RA; Doroshow, JH; Makhlouf, HR

Published Date

  • May 10, 2020

Published In

Volume / Issue

  • 38 / 14

Start / End Page

  • 1633 - 1640

PubMed ID

  • 32134701

Pubmed Central ID

  • PMC7351328

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

Digital Object Identifier (DOI)

  • 10.1200/JCO.19.02322


  • eng

Conference Location

  • United States